1 Disease Control and Prevention Vaccine Market Overview 1.1 Product Overview and Scope of Disease Control and Prevention Vaccine 1.2 Disease Control and Prevention Vaccine Segment by Type 1.2.1 Global Disease Control and Prevention Vaccine Market Value Comparison by Type (2023-2029) 1.2.2 Live-Attenuated 1.2.3 Inactivated 1.2.4 Recombinant Sub Unit and Toxoid 1.3 Disease Control and Prevention Vaccine Segment by Application 1.3.1 Global Disease Control and Prevention Vaccine Market Value by Application: (2023-2029) 1.3.2 Pediatric Vaccine 1.3.3 Adult Vaccine 1.4 Global Disease Control and Prevention Vaccine Market Size Estimates and Forecasts 1.4.1 Global Disease Control and Prevention Vaccine Revenue 2018-2029 1.4.2 Global Disease Control and Prevention Vaccine Sales 2018-2029 1.4.3 Global Disease Control and Prevention Vaccine Market Average Price (2018-2029) 1.5 Assumptions and Limitations 2 Disease Control and Prevention Vaccine Market Competition by Manufacturers 2.1 Global Disease Control and Prevention Vaccine Sales Market Share by Manufacturers (2018-2023) 2.2 Global Disease Control and Prevention Vaccine Revenue Market Share by Manufacturers (2018-2023) 2.3 Global Disease Control and Prevention Vaccine Average Price by Manufacturers (2018-2023) 2.4 Global Disease Control and Prevention Vaccine Industry Ranking 2021 VS 2022 VS 2023 2.5 Global Key Manufacturers of Disease Control and Prevention Vaccine, Manufacturing Sites & Headquarters 2.6 Global Key Manufacturers of Disease Control and Prevention Vaccine, Product Type & Application 2.7 Disease Control and Prevention Vaccine Market Competitive Situation and Trends 2.7.1 Disease Control and Prevention Vaccine Market Concentration Rate 2.7.2 The Global Top 5 and Top 10 Largest Disease Control and Prevention Vaccine Players Market Share by Revenue 2.7.3 Global Disease Control and Prevention Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.8 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Disease Control and Prevention Vaccine Retrospective Market Scenario by Region 3.1 Global Disease Control and Prevention Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029 3.2 Global Disease Control and Prevention Vaccine Global Disease Control and Prevention Vaccine Sales by Region: 2018-2029 3.2.1 Global Disease Control and Prevention Vaccine Sales by Region: 2018-2023 3.2.2 Global Disease Control and Prevention Vaccine Sales by Region: 2024-2029 3.3 Global Disease Control and Prevention Vaccine Global Disease Control and Prevention Vaccine Revenue by Region: 2018-2029 3.3.1 Global Disease Control and Prevention Vaccine Revenue by Region: 2018-2023 3.3.2 Global Disease Control and Prevention Vaccine Revenue by Region: 2024-2029 3.4 North America Disease Control and Prevention Vaccine Market Facts & Figures by Country 3.4.1 North America Disease Control and Prevention Vaccine Market Size by Country: 2018 VS 2022 VS 2029 3.4.2 North America Disease Control and Prevention Vaccine Sales by Country (2018-2029) 3.4.3 North America Disease Control and Prevention Vaccine Revenue by Country (2018-2029) 3.4.4 U.S. 3.4.5 Canada 3.5 Europe Disease Control and Prevention Vaccine Market Facts & Figures by Country 3.5.1 Europe Disease Control and Prevention Vaccine Market Size by Country: 2018 VS 2022 VS 2029 3.5.2 Europe Disease Control and Prevention Vaccine Sales by Country (2018-2029) 3.5.3 Europe Disease Control and Prevention Vaccine Revenue by Country (2018-2029) 3.5.4 Germany 3.5.5 France 3.5.6 U.K. 3.5.7 Italy 3.5.8 Russia 3.6 Asia Pacific Disease Control and Prevention Vaccine Market Facts & Figures by Country 3.6.1 Asia Pacific Disease Control and Prevention Vaccine Market Size by Country: 2018 VS 2022 VS 2029 3.6.2 Asia Pacific Disease Control and Prevention Vaccine Sales by Country (2018-2029) 3.6.3 Asia Pacific Disease Control and Prevention Vaccine Revenue by Country (2018-2029) 3.6.4 China 3.6.5 Japan 3.6.6 South Korea 3.6.7 India 3.6.8 Australia 3.6.9 Taiwan 3.6.10 Indonesia 3.6.11 Thailand 3.6.12 Malaysia 3.6.13 Philippines 3.7 Latin America Disease Control and Prevention Vaccine Market Facts & Figures by Country 3.7.1 Latin America Disease Control and Prevention Vaccine Market Size by Country: 2018 VS 2022 VS 2029 3.7.2 Latin America Disease Control and Prevention Vaccine Sales by Country (2018-2029) 3.7.3 Latin America Disease Control and Prevention Vaccine Revenue by Country (2018-2029) 3.7.4 Mexico 3.7.5 Brazil 3.7.6 Argentina 3.8 Middle East and Africa Disease Control and Prevention Vaccine Market Facts & Figures by Country 3.8.1 Middle East and Africa Disease Control and Prevention Vaccine Market Size by Country: 2018 VS 2022 VS 2029 3.8.2 Middle East and Africa Disease Control and Prevention Vaccine Sales by Country (2018-2029) 3.8.3 Middle East and Africa Disease Control and Prevention Vaccine Revenue by Country (2018-2029) 3.8.4 Turkey 3.8.5 Saudi Arabia 3.8.6 U.A.E 4 Segment by Type 4.1 Global Disease Control and Prevention Vaccine Sales by Type (2018-2029) 4.1.1 Global Disease Control and Prevention Vaccine Sales by Type (2018-2023) 4.1.2 Global Disease Control and Prevention Vaccine Sales by Type (2024-2029) 4.1.3 Global Disease Control and Prevention Vaccine Sales Market Share by Type (2018-2029) 4.2 Global Disease Control and Prevention Vaccine Revenue by Type (2018-2029) 4.2.1 Global Disease Control and Prevention Vaccine Revenue by Type (2018-2023) 4.2.2 Global Disease Control and Prevention Vaccine Revenue by Type (2024-2029) 4.2.3 Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2018-2029) 4.3 Global Disease Control and Prevention Vaccine Price by Type (2018-2029) 5 Segment by Application 5.1 Global Disease Control and Prevention Vaccine Sales by Application (2018-2029) 5.1.1 Global Disease Control and Prevention Vaccine Sales by Application (2018-2023) 5.1.2 Global Disease Control and Prevention Vaccine Sales by Application (2024-2029) 5.1.3 Global Disease Control and Prevention Vaccine Sales Market Share by Application (2018-2029) 5.2 Global Disease Control and Prevention Vaccine Revenue by Application (2018-2029) 5.2.1 Global Disease Control and Prevention Vaccine Revenue by Application (2018-2023) 5.2.2 Global Disease Control and Prevention Vaccine Revenue by Application (2024-2029) 5.2.3 Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2018-2029) 5.3 Global Disease Control and Prevention Vaccine Price by Application (2018-2029) 6 Key Companies Profiled 6.1 GSK 6.1.1 GSK Corporation Information 6.1.2 GSK Description and Business Overview 6.1.3 GSK Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2018-2023) 6.1.4 GSK Disease Control and Prevention Vaccine Product Portfolio 6.1.5 GSK Recent Developments/Updates 6.2 Merck & Co., Inc 6.2.1 Merck & Co., Inc Corporation Information 6.2.2 Merck & Co., Inc Description and Business Overview 6.2.3 Merck & Co., Inc Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2018-2023) 6.2.4 Merck & Co., Inc Disease Control and Prevention Vaccine Product Portfolio 6.2.5 Merck & Co., Inc Recent Developments/Updates 6.3 Pfizer 6.3.1 Pfizer Corporation Information 6.3.2 Pfizer Description and Business Overview 6.3.3 Pfizer Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2018-2023) 6.3.4 Pfizer Disease Control and Prevention Vaccine Product Portfolio 6.3.5 Pfizer Recent Developments/Updates 6.4 Sanofi 6.4.1 Sanofi Corporation Information 6.4.2 Sanofi Description and Business Overview 6.4.3 Sanofi Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2018-2023) 6.4.4 Sanofi Disease Control and Prevention Vaccine Product Portfolio 6.4.5 Sanofi Recent Developments/Updates 6.5 AstraZeneca PLC 6.5.1 AstraZeneca PLC Corporation Information 6.5.2 AstraZeneca PLC Description and Business Overview 6.5.3 AstraZeneca PLC Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2018-2023) 6.5.4 AstraZeneca PLC Disease Control and Prevention Vaccine Product Portfolio 6.5.5 AstraZeneca PLC Recent Developments/Updates 6.6 Sinovac Biotech Ltd 6.6.1 Sinovac Biotech Ltd Corporation Information 6.6.2 Sinovac Biotech Ltd Description and Business Overview 6.6.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2018-2023) 6.6.4 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product Portfolio 6.6.5 Sinovac Biotech Ltd Recent Developments/Updates 6.7 Astellas Pharma Inc 6.6.1 Astellas Pharma Inc Corporation Information 6.6.2 Astellas Pharma Inc Description and Business Overview 6.6.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2018-2023) 6.4.4 Astellas Pharma Inc Disease Control and Prevention Vaccine Product Portfolio 6.7.5 Astellas Pharma Inc Recent Developments/Updates 6.8 Serum Institute of India Pvt. Ltd 6.8.1 Serum Institute of India Pvt. Ltd Corporation Information 6.8.2 Serum Institute of India Pvt. Ltd Description and Business Overview 6.8.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2018-2023) 6.8.4 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product Portfolio 6.8.5 Serum Institute of India Pvt. Ltd Recent Developments/Updates 6.9 Daiichi Sankyo 6.9.1 Daiichi Sankyo Corporation Information 6.9.2 Daiichi Sankyo Description and Business Overview 6.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2018-2023) 6.9.4 Daiichi Sankyo Disease Control and Prevention Vaccine Product Portfolio 6.9.5 Daiichi Sankyo Recent Developments/Updates 7 Industry Chain and Sales Channels Analysis 7.1 Disease Control and Prevention Vaccine Industry Chain Analysis 7.2 Disease Control and Prevention Vaccine Key Raw Materials 7.2.1 Key Raw Materials 7.2.2 Raw Materials Key Suppliers 7.3 Disease Control and Prevention Vaccine Production Mode & Process 7.4 Disease Control and Prevention Vaccine Sales and Marketing 7.4.1 Disease Control and Prevention Vaccine Sales Channels 7.4.2 Disease Control and Prevention Vaccine Distributors 7.5 Disease Control and Prevention Vaccine Customers 8 Disease Control and Prevention Vaccine Market Dynamics 8.1 Disease Control and Prevention Vaccine Industry Trends 8.2 Disease Control and Prevention Vaccine Market Drivers 8.3 Disease Control and Prevention Vaccine Market Challenges 8.4 Disease Control and Prevention Vaccine Market Restraints 9 Research Finding and Conclusion 10 Methodology and Data Source 10.1 Methodology/Research Approach 10.1.1 Research Programs/Design 10.1.2 Market Size Estimation 10.1.3 Market Breakdown and Data Triangulation 10.2 Data Source 10.2.1 Secondary Sources 10.2.2 Primary Sources 10.3 Author List 10.4 Disclaimer

List of Tables Table 1. Global Disease Control and Prevention Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million) Table 2. Global Disease Control and Prevention Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million) Table 3. Global Disease Control and Prevention Vaccine Market Competitive Situation by Manufacturers in 2022 Table 4. Global Disease Control and Prevention Vaccine Sales (K Units) of Key Manufacturers (2018-2023) Table 5. Global Disease Control and Prevention Vaccine Sales Market Share by Manufacturers (2018-2023) Table 6. Global Disease Control and Prevention Vaccine Revenue (US$ Million) by Manufacturers (2018-2023) Table 7. Global Disease Control and Prevention Vaccine Revenue Share by Manufacturers (2018-2023) Table 8. Global Market Disease Control and Prevention Vaccine Average Price (USD/Unit) of Key Manufacturers (2018-2023) Table 9. Global Key Players of Disease Control and Prevention Vaccine, Industry Ranking, 2021 VS 2022 VS 2023 Table 10. Global Key Manufacturers of Disease Control and Prevention Vaccine, Manufacturing Sites & Headquarters Table 11. Global Key Manufacturers of Disease Control and Prevention Vaccine, Product Type & Application Table 12. Global Key Manufacturers of Disease Control and Prevention Vaccine, Date of Enter into This Industry Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Global Disease Control and Prevention Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Disease Control and Prevention Vaccine as of 2022) Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans Table 16. Global Disease Control and Prevention Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 17. Global Disease Control and Prevention Vaccine Sales by Region (2018-2023) & (K Units) Table 18. Global Disease Control and Prevention Vaccine Sales Market Share by Region (2018-2023) Table 19. Global Disease Control and Prevention Vaccine Sales by Region (2024-2029) & (K Units) Table 20. Global Disease Control and Prevention Vaccine Sales Market Share by Region (2024-2029) Table 21. Global Disease Control and Prevention Vaccine Revenue by Region (2018-2023) & (US$ Million) Table 22. Global Disease Control and Prevention Vaccine Revenue Market Share by Region (2018-2023) Table 23. Global Disease Control and Prevention Vaccine Revenue by Region (2024-2029) & (US$ Million) Table 24. Global Disease Control and Prevention Vaccine Revenue Market Share by Region (2024-2029) Table 25. North America Disease Control and Prevention Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 26. North America Disease Control and Prevention Vaccine Sales by Country (2018-2023) & (K Units) Table 27. North America Disease Control and Prevention Vaccine Sales by Country (2024-2029) & (K Units) Table 28. North America Disease Control and Prevention Vaccine Revenue by Country (2018-2023) & (US$ Million) Table 29. North America Disease Control and Prevention Vaccine Revenue by Country (2024-2029) & (US$ Million) Table 30. Europe Disease Control and Prevention Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 31. Europe Disease Control and Prevention Vaccine Sales by Country (2018-2023) & (K Units) Table 32. Europe Disease Control and Prevention Vaccine Sales by Country (2024-2029) & (K Units) Table 33. Europe Disease Control and Prevention Vaccine Revenue by Country (2018-2023) & (US$ Million) Table 34. Europe Disease Control and Prevention Vaccine Revenue by Country (2024-2029) & (US$ Million) Table 35. Asia Pacific Disease Control and Prevention Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million) Table 36. Asia Pacific Disease Control and Prevention Vaccine Sales by Region (2018-2023) & (K Units) Table 37. Asia Pacific Disease Control and Prevention Vaccine Sales by Region (2024-2029) & (K Units) Table 38. Asia Pacific Disease Control and Prevention Vaccine Revenue by Region (2018-2023) & (US$ Million) Table 39. Asia Pacific Disease Control and Prevention Vaccine Revenue by Region (2024-2029) & (US$ Million) Table 40. Latin America Disease Control and Prevention Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 41. Latin America Disease Control and Prevention Vaccine Sales by Country (2018-2023) & (K Units) Table 42. Latin America Disease Control and Prevention Vaccine Sales by Country (2024-2029) & (K Units) Table 43. Latin America Disease Control and Prevention Vaccine Revenue by Country (2018-2023) & (US$ Million) Table 44. Latin America Disease Control and Prevention Vaccine Revenue by Country (2024-2029) & (US$ Million) Table 45. Middle East & Africa Disease Control and Prevention Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 46. Middle East & Africa Disease Control and Prevention Vaccine Sales by Country (2018-2023) & (K Units) Table 47. Middle East & Africa Disease Control and Prevention Vaccine Sales by Country (2024-2029) & (K Units) Table 48. Middle East & Africa Disease Control and Prevention Vaccine Revenue by Country (2018-2023) & (US$ Million) Table 49. Middle East & Africa Disease Control and Prevention Vaccine Revenue by Country (2024-2029) & (US$ Million) Table 50. Global Disease Control and Prevention Vaccine Sales (K Units) by Type (2018-2023) Table 51. Global Disease Control and Prevention Vaccine Sales (K Units) by Type (2024-2029) Table 52. Global Disease Control and Prevention Vaccine Sales Market Share by Type (2018-2023) Table 53. Global Disease Control and Prevention Vaccine Sales Market Share by Type (2024-2029) Table 54. Global Disease Control and Prevention Vaccine Revenue (US$ Million) by Type (2018-2023) Table 55. Global Disease Control and Prevention Vaccine Revenue (US$ Million) by Type (2024-2029) Table 56. Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2018-2023) Table 57. Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2024-2029) Table 58. Global Disease Control and Prevention Vaccine Price (USD/Unit) by Type (2018-2023) Table 59. Global Disease Control and Prevention Vaccine Price (USD/Unit) by Type (2024-2029) Table 60. Global Disease Control and Prevention Vaccine Sales (K Units) by Application (2018-2023) Table 61. Global Disease Control and Prevention Vaccine Sales (K Units) by Application (2024-2029) Table 62. Global Disease Control and Prevention Vaccine Sales Market Share by Application (2018-2023) Table 63. Global Disease Control and Prevention Vaccine Sales Market Share by Application (2024-2029) Table 64. Global Disease Control and Prevention Vaccine Revenue (US$ Million) by Application (2018-2023) Table 65. Global Disease Control and Prevention Vaccine Revenue (US$ Million) by Application (2024-2029) Table 66. Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2018-2023) Table 67. Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2024-2029) Table 68. Global Disease Control and Prevention Vaccine Price (USD/Unit) by Application (2018-2023) Table 69. Global Disease Control and Prevention Vaccine Price (USD/Unit) by Application (2024-2029) Table 70. GSK Corporation Information Table 71. GSK Description and Business Overview Table 72. GSK Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 73. GSK Disease Control and Prevention Vaccine Product Table 74. GSK Recent Developments/Updates Table 75. Merck & Co., Inc Corporation Information Table 76. Merck & Co., Inc Description and Business Overview Table 77. Merck & Co., Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 78. Merck & Co., Inc Disease Control and Prevention Vaccine Product Table 79. Merck & Co., Inc Recent Developments/Updates Table 80. Pfizer Corporation Information Table 81. Pfizer Description and Business Overview Table 82. Pfizer Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 83. Pfizer Disease Control and Prevention Vaccine Product Table 84. Pfizer Recent Developments/Updates Table 85. Sanofi Corporation Information Table 86. Sanofi Description and Business Overview Table 87. Sanofi Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 88. Sanofi Disease Control and Prevention Vaccine Product Table 89. Sanofi Recent Developments/Updates Table 90. AstraZeneca PLC Corporation Information Table 91. AstraZeneca PLC Description and Business Overview Table 92. AstraZeneca PLC Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 93. AstraZeneca PLC Disease Control and Prevention Vaccine Product Table 94. AstraZeneca PLC Recent Developments/Updates Table 95. Sinovac Biotech Ltd Corporation Information Table 96. Sinovac Biotech Ltd Description and Business Overview Table 97. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 98. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product Table 99. Sinovac Biotech Ltd Recent Developments/Updates Table 100. Astellas Pharma Inc Corporation Information Table 101. Astellas Pharma Inc Description and Business Overview Table 102. Astellas Pharma Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 103. Astellas Pharma Inc Disease Control and Prevention Vaccine Product Table 104. Astellas Pharma Inc Recent Developments/Updates Table 105. Serum Institute of India Pvt. Ltd Corporation Information Table 106. Serum Institute of India Pvt. Ltd Description and Business Overview Table 107. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 108. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product Table 109. Serum Institute of India Pvt. Ltd Recent Developments/Updates Table 110. Daiichi Sankyo Corporation Information Table 111. Daiichi Sankyo Description and Business Overview Table 112. Daiichi Sankyo Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 113. Daiichi Sankyo Disease Control and Prevention Vaccine Product Table 114. Daiichi Sankyo Recent Developments/Updates Table 115. Key Raw Materials Lists Table 116. Raw Materials Key Suppliers Lists Table 117. Disease Control and Prevention Vaccine Distributors List Table 118. Disease Control and Prevention Vaccine Customers List Table 119. Disease Control and Prevention Vaccine Market Trends Table 120. Disease Control and Prevention Vaccine Market Drivers Table 121. Disease Control and Prevention Vaccine Market Challenges Table 122. Disease Control and Prevention Vaccine Market Restraints Table 123. Research Programs/Design for This Report Table 124. Key Data Information from Secondary Sources Table 125. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Disease Control and Prevention Vaccine Figure 2. Global Disease Control and Prevention Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million) Figure 3. Global Disease Control and Prevention Vaccine Market Share by Type in 2022 & 2029 Figure 4. Live-Attenuated Product Picture Figure 5. Inactivated Product Picture Figure 6. Recombinant Sub Unit and Toxoid Product Picture Figure 7. Global Disease Control and Prevention Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million) Figure 8. Global Disease Control and Prevention Vaccine Market Share by Application in 2022 & 2029 Figure 9. Pediatric Vaccine Figure 10. Adult Vaccine Figure 11. Global Disease Control and Prevention Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029 Figure 12. Global Disease Control and Prevention Vaccine Market Size (2018-2029) & (US$ Million) Figure 13. Global Disease Control and Prevention Vaccine Sales (2018-2029) & (K Units) Figure 14. Global Disease Control and Prevention Vaccine Average Price (USD/Unit) & (2018-2029) Figure 15. Disease Control and Prevention Vaccine Report Years Considered Figure 16. Disease Control and Prevention Vaccine Sales Share by Manufacturers in 2022 Figure 17. Global Disease Control and Prevention Vaccine Revenue Share by Manufacturers in 2022 Figure 18. The Global 5 and 10 Largest Disease Control and Prevention Vaccine Players: Market Share by Revenue in 2022 Figure 19. Disease Control and Prevention Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022 Figure 20. Global Disease Control and Prevention Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Figure 21. North America Disease Control and Prevention Vaccine Sales Market Share by Country (2018-2029) Figure 22. North America Disease Control and Prevention Vaccine Revenue Market Share by Country (2018-2029) Figure 23. U.S. Disease Control and Prevention Vaccine Revenue Growth Rate (2018-2029) & (US$ Million) Figure 24. Canada Disease Control and Prevention Vaccine Revenue Growth Rate (2018-2029) & (US$ Million) Figure 25. Europe Disease Control and Prevention Vaccine Sales Market Share by Country (2018-2029) Figure 26. Europe Disease Control and Prevention Vaccine Revenue Market Share by Country (2018-2029) Figure 27. Germany Disease Control and Prevention Vaccine Revenue Growth Rate (2018-2029) & (US$ Million) Figure 28. France Disease Control and Prevention Vaccine Revenue Growth Rate (2018-2029) & (US$ Million) Figure 29. U.K. Disease Control and Prevention Vaccine Revenue Growth Rate (2018-2029) & (US$ Million) Figure 30. Italy Disease Control and Prevention Vaccine Revenue Growth Rate (2018-2029) & (US$ Million) Figure 31. Russia Disease Control and Prevention Vaccine Revenue Growth Rate (2018-2029) & (US$ Million) Figure 32. Asia Pacific Disease Control and Prevention Vaccine Sales Market Share by Region (2018-2029) Figure 33. Asia Pacific Disease Control and Prevention Vaccine Revenue Market Share by Region (2018-2029) Figure 34. China Disease Control and Prevention Vaccine Revenue Growth Rate (2018-2029) & (US$ Million) Figure 35. Japan Disease Control and Prevention Vaccine Revenue Growth Rate (2018-2029) & (US$ Million) Figure 36. South Korea Disease Control and Prevention Vaccine Revenue Growth Rate (2018-2029) & (US$ Million) Figure 37. India Disease Control and Prevention Vaccine Revenue Growth Rate (2018-2029) & (US$ Million) Figure 38. Australia Disease Control and Prevention Vaccine Revenue Growth Rate (2018-2029) & (US$ Million) Figure 39. Taiwan Disease Control and Prevention Vaccine Revenue Growth Rate (2018-2029) & (US$ Million) Figure 40. Indonesia Disease Control and Prevention Vaccine Revenue Growth Rate (2018-2029) & (US$ Million) Figure 41. Thailand Disease Control and Prevention Vaccine Revenue Growth Rate (2018-2029) & (US$ Million) Figure 42. Malaysia Disease Control and Prevention Vaccine Revenue Growth Rate (2018-2029) & (US$ Million) Figure 43. Philippines Disease Control and Prevention Vaccine Revenue Growth Rate (2018-2029) & (US$ Million) Figure 44. Latin America Disease Control and Prevention Vaccine Sales Market Share by Country (2018-2029) Figure 45. Latin America Disease Control and Prevention Vaccine Revenue Market Share by Country (2018-2029) Figure 46. Mexico Disease Control and Prevention Vaccine Revenue Growth Rate (2018-2029) & (US$ Million) Figure 47. Brazil Disease Control and Prevention Vaccine Revenue Growth Rate (2018-2029) & (US$ Million) Figure 48. Argentina Disease Control and Prevention Vaccine Revenue Growth Rate (2018-2029) & (US$ Million) Figure 49. Middle East & Africa Disease Control and Prevention Vaccine Sales Market Share by Country (2018-2029) Figure 50. Middle East & Africa Disease Control and Prevention Vaccine Revenue Market Share by Country (2018-2029) Figure 51. Turkey Disease Control and Prevention Vaccine Revenue Growth Rate (2018-2029) & (US$ Million) Figure 52. Saudi Arabia Disease Control and Prevention Vaccine Revenue Growth Rate (2018-2029) & (US$ Million) Figure 53. U.A.E Disease Control and Prevention Vaccine Revenue Growth Rate (2018-2029) & (US$ Million) Figure 54. Global Sales Market Share of Disease Control and Prevention Vaccine by Type (2018-2029) Figure 55. Global Revenue Market Share of Disease Control and Prevention Vaccine by Type (2018-2029) Figure 56. Global Disease Control and Prevention Vaccine Price (USD/Unit) by Type (2018-2029) Figure 57. Global Sales Market Share of Disease Control and Prevention Vaccine by Application (2018-2029) Figure 58. Global Revenue Market Share of Disease Control and Prevention Vaccine by Application (2018-2029) Figure 59. Global Disease Control and Prevention Vaccine Price (USD/Unit) by Application (2018-2029) Figure 60. Disease Control and Prevention Vaccine Value Chain Figure 61. Disease Control and Prevention Vaccine Production Process Figure 62. Channels of Distribution (Direct Vs Distribution) Figure 63. Distributors Profiles Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed

GSK Merck & Co., Inc Pfizer Sanofi AstraZeneca PLC Sinovac Biotech Ltd Astellas Pharma Inc Serum Institute of India Pvt. Ltd Daiichi Sankyo